Provided by Tiger Trade Technology Pte. Ltd.

Warren Buffett holdings

3,235.82
+21.220.66%
Number of Gainers:12
Number of Losers:23
Number of Flat:- -
PE:- -
High:3,241.58
Open:3,228.19
Low:3,201.12
Close:3,214.60
Volume:296.45M
Turnover:38.11B
Market Cap:11.51T
Float Cap:10.93T

Loading ...

Sector Update: Consumer

MT Newswires Live
·
Yesterday

India's Jubilant FoodWorks Posts Higher Quarterly Revenue as Domino's Sales Pick Up

Reuters
·
Yesterday

Dollar Climbs Ahead of Fed Minutes; Euro Slides Towards 17-Month Lows

Reuters
·
Yesterday

BofA Securities Adjusts Ally Financial Price Target to $44 From $49

MT Newswires Live
·
Yesterday

AbbVie’s telisotuzumab adizutecan gets two FDA Breakthrough Therapy Designations

TIPRANKS
·
Yesterday

Tempus AI announces multi-year collaboration with Moderna, Merck

TIPRANKS
·
Yesterday

Halozyme announces Dutch court of the Hague found Merck infringed patents

TIPRANKS
·
Yesterday

AbbVie Says FDA Grants Breakthrough Therapy Status for ABBV-400 in Metastatic Colorectal Cancer

Reuters
·
Yesterday

Tempus Expands Multi-Year Collaboration with Moderna, Merck on V940 Melanoma Vaccine Commercialization Support

Reuters
·
Yesterday

Analysts Offer Insights on Consumer Cyclical Companies: MTY Food Group (OtherMTYFF) and Amazon (AMZN)

TIPRANKS
·
Yesterday

Halozyme Therapeutics - Iv Version of Keytruda Remains Available and not Covered by Halozyme's Patent or Court Injunction

THOMSON REUTERS
·
Yesterday

Halozyme Therapeutics - Court Rejects Merck's Arguments That Ep622 Patent is Invalid

THOMSON REUTERS
·
Yesterday

Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda Sc in Multiple European Markets

THOMSON REUTERS
·
Yesterday

Halozyme Therapeutics - Court Orders Msd BV to Stop Keytruda Sc Manufacture and Sale in Eight European Countries

THOMSON REUTERS
·
Yesterday

Halozyme Therapeutics - Injunction Forbids Msd from Facilitating Infringement by Affiliates

THOMSON REUTERS
·
Yesterday

Tempus Announces Multi-Year Collaboration with Moderna and Merck

THOMSON REUTERS
·
Yesterday

Morgan Stanley Adjusts Moody's Price Target to $470 From $512, Maintains Equal Weight Rating

MT Newswires Live
·
Yesterday

Five More UK Rate-Rigging Convictions Quashed as SFO Prosecutions Unravel

Reuters
·
Yesterday

Visa (V) or Mastercard (MA): Which Payment Stock Offers More Upside?

TIPRANKS
·
Yesterday

U.S. Stocks on the MOVE-Intel, Vaxcyte, Constellation Brands

Reuters
·
Yesterday